Importance of research on peptidylarginine deiminase and citrullinated proteins in age-related disease

Geriatrics and Gerontology International

Volumn 10, Issue SUPPL. 1, 2010, Pages

  Ishigami, Akihito ^a   Maruyama, Naoki ^b  

^a TOHO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Aging; Alzheimer's disease; Citrullinated proteins; Epidermal differentiation; Peptidylarginine deiminase

Indexed keywords

ARGININE; BRAIN PROTEIN; CALCIUM ION; CITRULLINE; FILAGGRIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID; KERATIN; MONOMER; PROFILAGGRIN; PROTEIN; PROTEIN ARGININE DEIMINASE; HYDROLASE; PROTEIN-ARGININE DEIMINASE;

AGING; ALZHEIMER DISEASE; BRAIN; BRAIN CORTEX; BRAIN LEVEL; CELL DIFFERENTIATION; CELL FREE SYSTEM; CELL LINE; CENTRAL NERVOUS SYSTEM; EPIDERMIS; GLIA CELL; GRANULAR CELL; HIPPOCAMPUS; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; KERATINOCYTE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROGLIA; MOLECULAR WEIGHT; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PYRAMIDAL NERVE CELL; RESEARCH; REVIEW; SENILE PLAQUE; SKIN; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DEGENERATIVE DISEASE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CITRULLINE; EPIDERMIS; HIPPOCAMPUS; HUMANS; HYDROLASES; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; NEURODEGENERATIVE DISEASES;

EID: 77954661595     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2010.00593.x     Document Type: Review

References (41)

1. Kubilus J, Waitkus RF, Baden HP. Partial purification and specificity of an arginine-converting enzyme from bovine epidermis. Biochim Biophys Acta 1980, 615:246-251.
2. Rogers GE, Simmonds DH. Content of citrulline and other amino acids in a protein of hair follicles. Nature 1958, 182:186-187.
3. Kubilus J, Baden HP. Purification and properties of a brain enzyme which deiminates proteins. Biochim Biophys Acta 1983, 745:285-291.
4. Ishigami A, Ohsawa T, Watanabe K, Senshu T. All-trans retinoic acid increases peptidylarginine deiminases in a newborn rat keratinocyte cell line. Biochem Biophys Res Commun 1996, 223:299-303.
5. Imparl JM, Senshu T, Graves DJ. Studies of calcineurin-calmodulin interaction: probing the role of arginine residues using peptidylarginine deiminase. Arch Biochem Biophys 1995, 318:370-377.
6. Lamensa JW, Moscarello MA. Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain. J Neurochem 1993, 61:987-996.
7. Tarcsa E, Marekov LN, Mei G, Melino G, Lee S-C, Steinert PM. Protein Unfolding by Peptidylarginine Deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996, 271:30709-30716.
8. Senshu T, Akiyama K, Ishigami A, Nomura K. Studies on specificity of peptidylarginine deiminase reactions using an immunochemical probe that recognizes an enzymatically deiminated partial sequence of mouse keratin K1. J Dermatol Sci 1999, 21:113-126.
9. Senshu T, Akiyama K, Kan S, Asaga H, Ishigami A, Manabe M. Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. J Invest Dermatol 1995, 105:163-169.
10. Ishigami A, Ohsawa T, Hiratsuka M. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 2005, 80:120-128.
11. Watanabe K, Akiyama K, Hikichi K, Ohtsuka R, Okuyama A, Senshu T. Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochim Biophys Acta 1988, 966:375-383.
12. Terakawa H, Takahara H, Sugawara K. Three types of mouse peptidylarginine deiminase: characterization and tissue distribution. J Biochem (Tokyo) 1991, 110:661-666.
13. Ishigami A, Kuramoto M, Yamada M, Watanabe K, Senshu T. Molecular cloning of two novel types of peptidylarginine deiminase cDNAs from retinoic acid-treated culture of a newborn rat keratinocyte cell line. FEBS Lett 1998, 433:113-118.
14. Tsuchida M, Takahara H, Minami N. cDNA nucleotide sequence and primary structure of mouse uterine peptidylarginine deiminase. Detection of a 3′-untranslated nucleotide sequence common to the mRNA of transiently expressed genes and rapid turnover of this enzyme's mRNA in the estrous cycle. Eur J Biochem 1993, 215:677-685.
15. Watanabe K, Senshu T. Isolation and characterization of cDNA clones encoding rat skeletal muscle peptidylarginine deiminase. J Biol Chem 1989, 264:15255-15260.
16. Nishijyo T, Kawada A, Kanno T, Shiraiwa M, Takahara H. Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat. J Biochem (Tokyo) 1997, 121:868-875.
17. Rus'd AA, Ikejiri Y, Ono H. Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. Eur J Biochem 1999, 259:660-669.
18. Ishigami A, Asaga H, Ohsawa T, Akiyama K, Maruyama N. Peptidylarginine deiminase type I, type II, type III and type IV are expressed in rat epidermis. Biomed Res 2001, 22:63-65.
19. Guerrin M, Ishigami A, Mechin MC. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochem J 2003, 370:167-174.
20. Ishigami A, Ohsawa T, Asaga H, Akiyama K, Kuramoto M, Maruyama N. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. Arch Biochem Biophys 2002, 407:25-31.
21. Kanno T, Kawada A, Yamanouchi J. Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. J Invest Dermatol 2000, 115:813-823.
22. Nakashima K, Hagiwara T, Ishigami A. Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J Biol Chem 1999, 274:27786-27792.
23. Chavanas S, Mechin MC, Takahara H. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene 2004, 330:19-27.
24. Asaga H, Nakashima K, Senshu T, Ishigami A, Yamada M. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J Leukocyte Biol 2001, 70:46-51.
25. Baden HP, Kubilus J. The growth and differentiation of cultured newborn rat keratinocytes. J Invest Dermatol 1983, 80:124-130.
26. Ishigami A, Asaga H, Ohsawa T, Akiyama K, Maruyama N. Protein deimination and peptidylarginine deiminase expression during cornification of rat epidermal keratinocytes. Biomed Res 2002, 23:145-151.
27. Resing KA, al-Alawi N, Blomquist C, Fleckman P, Dale BA. Independent regulation of two cytoplasmic processing stages of the intermediate filament-associated protein filaggrin and role of Ca2+ in the second stage. J Biol Chem 1993, 268:25139-25145.
28. Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer's disease. J Neurochem 2000, 75:436-439.
29. Maccioni RB, Munoz JP, Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 2001, 32:367-381.
30. Asaga H, Ishigami A. Protein deimination in the rat brain: generation of citrulline-containing proteins in cerebrum perfused with oxygen-deprived media. Biomed Res 2000, 21:197-205.
31. Vincent SR, Leung E, Watanabe K. Immunohistochemical localization of peptidylarginine deiminase in the rat brain. J Chem Neuroanat 1992, 5:159-168.
32. Asaga H, Ishigami A. Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration. Neurosci Lett 2001, 299:5-8.
33. Asaga H, Akiyama K, Ohsawa T, Ishigami A. Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain. Neurosci Lett 2002, 326:129-132.
34. Akiyama K, Sakurai Y, Asou H, Senshu T. Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere. Neurosci Lett 1999, 274:53-55.
35. Senshu T, Sato T, Inoue T, Akiyama K, Asaga H. Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem 1992, 203:94-100.
36. Asaga H, Senshu T. Combined biochemical and immunocytochemical analyses of postmortem protein deimination in the rat spinal cord. Cell Biol Int 1993, 17:525-532.
37. Katzman R. Alzheimer's disease. N Engl J Med 1986, 314:964-973.
38. Smith MA. Alzheimer disease. Int Rev Neurobiol 1998, 42:1-54.
39. Hossmann KA. The hypoxic brain. Insights from ischemia research. Adv Exp Med Biol 1999, 474:155-169.
40. Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988, 11:465-469.
41. Haun SE, Murphy EJ, Bates CM, Horrocks LA. Extracellular calcium is a mediator of astroglial injury during combined glucose-oxygen deprivation. Brain Res 1992, 593:45-50.